Lv34
282 积分 2022-10-18 加入
Efficacy and safety of cefiderocol or best available therapy for the treatment of serious infections caused by carbapenem-resistant Gram-negative bacteria (CREDIBLE-CR): a randomised, open-label, multicentre, pathogen-focused, descriptive, phase 3 trial
33分钟前
待确认
Current and future options for the treatment of serious infections due to carbapenem-resistant Pseudomonas aeruginosa
1小时前
已完结
Pharmacokinetics/pharmacodynamics of cefiderocol administered by continuous infusion in a case series of critically ill patients with carbapenem-resistant Acinetobacter baumannii infections undergoing continuous venovenous haemodiafiltration (CVVHDF)
1天前
已完结
An Assessment Of Cefiderocol's Synergistic Effects With Eravacycline, Colistin, Meropenem, Levofloxacin, Ceftazidime/avibactam, And Tobramycin Against Carbapenem-Resistant and -Susceptible Pseudomonas aeruginosa
1天前
已完结
Cefiderocol: A Comprehensive Review of Chemistry, Mechanisms of Resistance, and Clinical Applications in the Era of Multidrug Resistance
1天前
已完结
Recent updates in treating carbapenem-resistant infections in patients with hematological malignancies
1天前
已完结
血液肿瘤患者碳青霉烯类耐药肠杆菌科细菌(CRE)感染的诊治与防控中国专家共识(2025年版)
2天前
已完结
Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
4天前
已完结
Quality of life is maintained with ixazomib maintenance in post‐transplant newly diagnosed multiple myeloma: The TOURMALINE‐MM3 trial
5天前
已完结
皖公网安备34019202002308
